This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Adapalene and benzoyl peroxide

Read time: 1 mins
Marketing start date: 21 Dec 2024
...
 

Summary of product characteristics


Effective Time

20220606

Version

1

Spl Product Data Elements

Adapalene and benzoyl peroxide Adapalene and benzoyl peroxide ADAPALENE ADAPALENE BENZOYL PEROXIDE BENZOYL PEROXIDE DOCUSATE SODIUM EDETATE DISODIUM GLYCERIN ISOHEXADECANE POLOXAMER 124 POLYSORBATE 80 PROPYLENE GLYCOL SODIUM ACRYLOYLDIMETHYLTAURATE-ACRYLAMIDE COPOLYMER (1:1; 90000-150000 MPA.S) SORBITAN MONOOLEATE WATER white to very pale yellow

Application Number

ANDA214553

Brand Name

Adapalene and benzoyl peroxide

Generic Name

Adapalene and benzoyl peroxide

Product Ndc

70771-1716

Product Type

HUMAN PRESCRIPTION DRUG

Route

TOPICAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Adapalene and benzoyl peroxide gel 0.3%/2.5% NDC 70771-1716-4 45 g Rx only container label carton label

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.